Burnham Hires Paul Laikind

Luke Timmerman10/21/09

The La Jolla, CA-based Burnham Institute for Medical Research said it has hired Paul Laikind, the co-founder of Gensia Pharmaceuticals, Viagene, and Metabasis, to be the institute’s senior vice president of business development and chief business officer. The hiring is a sign of the Burnham’s increasing emphasis on spinning out technologies, and forming deals with partners who can further develop and commercialize its ideas, said Greg Lucier, the chairman of the Burnham board of trustees, in a statement.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.